| NCT Number | NCT07597824 |
| Lead Sponsor | University of Alabama at Birmingham
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID), Beth Israel Deaconess Medical Center, Harvard School of Public Health (HSPH) |
| Conditions | HIV Infections, Contraception, PrEP |
| Enrollment | 1,000 participants |
| Start Date | 2026-06 |
| Primary Completion | 2031-12 (estimated) |
| Study Completion | 2031-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-25 |